Immunological aspects of cancer chemotherapy

Laurence Zitvogel(Institut Gustave Roussy), Lionel Apétoh(Université Paris-Saclay), François Ghiringhelli(Université Paris-Saclay), Guido Kroemer(Inserm)
Nature reviews. Immunology
December 21, 2007
10.1038/nri2216
Cited by 1,676Open Access
Full Text

Abstract

Related Papers

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Guido Kroemer, Lorenzo Galluzzi, Peter Vandenabeele et al.|Cell Death and Differentiation|2008|3.3k
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce et al.|Nature|2001|2.8k
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Stephan Gasser, Sandra Oršulić, Eric J. Brown et al.|Nature|2005|1.3k
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
François Ghiringhelli, Cédric Menard, Pierre E. Puig et al.|Cancer Immunology Immunotherapy|2006|1.2k
Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo
Nadine Fernandez, Anne Lozier, Caroline Flament et al.|Nature Medicine|1999|1k